Key facts
- Genomics has launched the Mystra AI platform.
- The platform uses the world's largest human genetics database.
- Mystra AI is designed for target discovery and validation in drug development.
- The platform is accessible to scientists in R&D and Business Development & Licensing.
- Both industry giants and smaller biotechs are adopting the platform.
The development of advanced AI platforms is rapidly transforming various industries, including healthcare and biotechnology. Mystra AI's launch signifies a move towards more sophisticated AI-driven solutions for complex scientific challenges like drug discovery, potentially speeding up the process and reducing costs.